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21. Current literature highlights
1.1. 1,4-Benzodiazepine-2,5-dione melanocortin receptor
agonists
The melanocortin receptor (MCR) system comprises ﬁve
distinct G-protein coupled receptors which upon binding
of an agonist stimulate the cAMP signal transduction path-
way. These receptors provide a number of opportunities
for drug discovery with synthetic agonists or antagonists.
For example agonists selective for the melanocortin 4
receptor (MC4R) could be used as agents to treat obesity.
Information from SAR studies around peptides has been
used in the design of peptidomimetics and small molecule
peptide mimics that could bind to the MCRs. In particular
the benzodiazepine family is know to mimic peptides, and a
recent publication has focussed on the 1,4-benzodiazepine-
2,5-dione structure as a mimic of the Phe-Arg-Tyr sequence
found in potent full agonists against the MCRs.1
A solid-phase synthetic approach to 1,4-benzodiazepine-
2,5-diones (1) was developed commencing with the immo-
bilisation of an a-amino ester to the support, followed by
acylation with an anthranilic acid, base-catalysed lactami-
sation, alkylation and cleavage. The approach relies on
the incorporation of three diversity elements: anthranilic
acids (R1), alkylating agents (R2) and a-amino esters
(R3). Twelve compounds were generated and fully ana-
lysed, and then subsequently screened for activity at the
mouse melanocortin receptors MC1R, MC3R, MC4R
and MC5R.
It was found the this group of compounds was particularly
revealing about the murine MC1R and MC4R pharmaco-
phores. Several of the compounds showed activity against
these receptors, and one compound in particular (2) was
a low nanomolar agonist. Agonist EC50 values of 48 nMdoi:10.1016/j.comche.2008.05.001
E-mail: nterrett@ensemblediscovery.comand 87 nM were measured against mMC1R and mMC5R
respectively. This approach demonstrates the value of the
1,4-benzodiazepine-2,5-dione structure as a melanocortin
receptor agonist and the solid-phase preparation route
used is suﬃciently ﬂexible to permit the generation of lar-
ger libraries of compounds.
1.2. Cyclic peptidyl inhibitors of Grb2 and tensin SH2
domains from combinatorial libraries
Cyclic peptides are widely produced in nature by plants,
bacteria, fungi and marine invertebrates and can provide
a rich source of biological activity. Their cyclic structure
confers a high degree of metabolic stability and the reduced
conformational ﬂexibility can result in higher aﬃnities for
protein targets. Despite the attractiveness of cyclic peptides
for drug discovery there have been very few reports of com-
binatorial libraries, possibly due to diﬃculties in structural
analysis by Edman degradation. A recent paper describes a
method for the creation of cyclic peptide libraries that also
provides a ready method for postscreening structure
identiﬁcation.2
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are spatially segregated into outer and inner layers, where
the cyclic peptide can be displayed on the surface, and
the interior of the bead contains the corresponding linear
peptide. During screening, the macromolecular target can
only access the cyclic peptides on the surface as it cannot
diﬀuse into the interior of the bead. After identiﬁcation
of an active peptide, the linear sequences can be determined
by partial Edman degradation/mass spectrometry.
Src homology-2 (SH2) domains are small domains in pro-
teins that mediate phosphorylation-dependent protein-pro-
tein interactions. Many SH2 domains have been implicated
in disease and thus present drug discovery targets—two
such are the SH2 domains of Grb2, an attractive anti-can-
cer target, and of tensin, a cytoplasmic protein that con-
nects points of adhesion to actin. The feasibility of the
cyclic peptide library approach has been demonstrated by
the synthesis and screening of peptide libraries against
these two SH2 domain targets.
As SH2 domains bind to phosphotyrosine (pY) containing-
motifs, the cyclic peptide libraries were based on pY pep-
tides and contained 10 amino acids in the form: cyclo-
(AXXpYXXXLNE)BBRM-resin, where B is b-alanine
and X is 2-L-aminobutyrate, norleucine or any of 18 natu-
ral amino acids (excluding cysteine and methionine). A sec-
ond library was based on the same structure but had
varying numbers of alanines. The theoretical diversity of
the libraries was 3.2 x 106 and 8.0 x 105 respectively. The
libraries were screened against the two SH2 targets, and
one cyclic peptide in particular had aﬃnity for Grb2 SH2
domain, and furthermore was shown to disrupt the actin
cytoskeleton and inhibit growth of human breast cancer
cells.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A solid-phase synthesis of 3,4-disubstituted 1-(x-hydroxy-
alkyl) imidazolin-2-ones on the ‘volatilisable’ aminoalkyl
functionalised silica gel has been reported. The desired
products were cleaved by a two-step procedure in good
purity and yield.3
The Boc-N-methyl-N-[2-(methylamino)ethyl]carbamoyl
group (Boc-Nmec) has been reported as a new side chain-
protective group for tyrosine in Fmoc solid-phase peptide
synthesis. Tyrosine is incorporated into the peptide as
Fmoc-Tyr(Boc-Nmec)-OH by standard coupling methods,
and during the cleavage of the peptide from the resin with
TFA the Boc group is simultaneously cleaved while the cat-
ionic N-methyl-N-[2-(methylamino)ethyl]carbamoyl group
remains attached to the tyrosine residue, thereby increasing
the solubility of the peptide. After puriﬁcation, the Nmec
protective group can be cleaved under neutral or mild alka-
line conditions via an intramolecular cyclisation reaction.4
In the course of the chemical synthesis of human protein
mitogaligin, a simple method to prepare peptide thioestersusing Fmoc chemistry was developed. The hydroxyl side
chain of serine was reacted with a trichloroacetimidate
Wang resin to anchor it on solid phase. After peptide elon-
gation and orthogonal unmasking of the C-terminus, the
amino thioester was introduced under optimised conditions
to avoid epimerisation.52.2. Solution-phase synthesis
The microwave heated Suzuki–Miyaura cross-coupling
reaction of boronic acids, boronic esters and organotriﬂu-
oroborates has been optimised and transferred to multi-
mode equipment which is well suited for multiparallel
synthesis on a larger scale. The source of the Pd species
chosen included immobilised Pd complexes and Pd parti-
cles, and the nature of the boronic acid had no impact on
the eﬃciency of the catalytic process.6
A highly versatile and general ionic liquid phase protocol
for the synthesis of new functionalised 3,4-dihydropyrimi-
dine-2(1H)-ones has been developed. This approach is par-
ticularly attractive for the preparation of 3,4-DHPMs
bearing a thiazole ring as bioisostere group in N-3 position
with good overall yields using Biginelli and Hantzsch reac-
tions. The scope and the potential of the 3-cyanomethyl
3,4-DHPM grafted on the ionic liquid phase is being
explored for the preparation and biological screening of a
wider library.7
The enantioselective synthesis of an avb3 integrin antago-
nist intermediate was approached via asymmetric hydro-
genation of a b,b-disubstituted-a,b-unsaturated ester. As
a result of the rapid parallel screening of a selection of
ligands and catalysts, it was found that neutral Me-
BoPhoz-rhodium and iridium catalysts achieve the
required transformation with a high enantioselectivity.82.3. Scaﬀolds for combinatorial libraries
A variety of 2,4-disubstituted-5-acetoxythiazoles have been
prepared from substituted methyl benzoates in good to
moderate yields using a three-step sequence: (1) ester to thi-
onoester conversion, (2) coupling with an amino acid, and
(3) acetic anhydride mediated cyclisation. This methodo-
logy can be readily applied to the synthesis of thiazole-
based chemical libraries.9
The synthesis of peptide–furostane conjugates from natural
steroidal sapogenins has been reported. The approach
comprises the introduction of a-oriented amino groups
into spirostanic sapogenins followed by reductive opening
of the spiroketal chain, thus producing diamino-furostanic
scaﬀolds suitable for further functionalisation. Solid and
solution-phase coupling processes were utilised for the
incorporation of various a-amino acids and peptides into
the furostanic skeletons. This work constitutes the ﬁrst
report on the use of furostanic sapogenins as scaﬀolds for
positioning natural amino acids and (cyclo)peptides.10
The broad and potent activity of 4-thiazolidinones has
established it as one of the biologically important scaﬀolds.
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inones and the promise they hold for the future.11
2.4. Solid-phase supported reagents
No papers this month.
2.5. Novel resins, linkers and techniques
Mammalian lipoxygenases have been implicated in a num-
ber of inﬂammation-related human diseases. The synthesis
of linoleic acid and (11,11)-d2-linoleic acid which are com-
binatorially labelled at the vinylic positions have been
reported allowing for the simultaneous determination of
kinetic isotope eﬀect in enzymatic reactions using NMR.12
New 30-terminal deoxyribonucleoside-loading reagents
with a new silyl-type linker have been developed. These
reagents could increase the eﬃciency of introduction of
30-terminal deoxyribonucleoside components into polymer
supports and allow the synthesis of unmodiﬁed DNA olig-
omers and also a base-labile modiﬁed DNA oligomer.13
A mild new procedure for preparing protected peptide thio-
esters, based on Ca2+-assisted thiolysis of peptide–Kaiser
oxime resin (KOR) linkage, has been described. A model
peptide was readily released from the resin by incubating
the peptide–KOR at 60C in mixtures of DMF with
n-butanethiol or ethyl 3-mercaptopropionate containing
Ca(CH3COO)2.
14
2.6. Library applications
Sulphamoyl benzamides have been identiﬁed as a novel ser-
ies of cannabinoid receptor ligands. Starting from a screen-
ing hit with modest aﬃnity for the cannabinoid CB2
receptor, a parallel synthesis approach was investigated
leading to a compound with 120-fold functional selectivity
for the CB2 receptor.
15
In a study on the development of new anticonvulsants, a
library of variously substituted N-phenylamino pyrrol-
idine-2,5-dione and hexahydro-isoindole-1,3-dione deriva-
tives was synthesised. The anticonvulsant activity of all
the compounds was evaluated using maximal electroshock
(MES) and pentylenetetrazole (scPTZ) screens, revealing
that the majority of compounds were eﬀective.16
The glycolytic pathway has been considered a potential
drug target against the parasitic protozoan species of Try-
panosoma and Leishmania. Stepwise library synthesis and
inhibitor design from a rational starting point identiﬁed
furanose sugar amino amides as a novel class of inhibitors
for Trypanosoma brucei phosphofructokinase (PFK) and
Leishmania mexicana pyruvate kinase (PyK).17References
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